Search for COVID19 targets
You are searching for: Phase 2 Trial
T97729 Target Info |
Target Name | HUMAN two pore channel subtype 2 (TPC2) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Amiodarone | Drug Info |
T99009 Target Info |
Target Name | HUMAN dihydroorotate dehydrogenase (DHODH) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS) | ||
Drugs | IMU-838 | Drug Info |
T94501 Target Info |
Target Name | HUMAN complement C5 alpha (C5A) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | IFX-1 | Drug Info |
T94307 Target Info |
Target Name | HUMAN interferon gamma (IFNG) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Emapalumab | Drug Info |
T99993 Target Info |
Target Name | HUMAN vascular endothelial growth factor (VEGF) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Bevacizumab | Drug Info |
T87374 Target Info |
Target Name | COVID-19 spike glycoprotein (S) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Nafamostat | Drug Info |
T99908 Target Info |
Target Name | HUMAN transmembrane protease serine 2 (TMPRSS2) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS) | ||
Drugs | Camostat mesylate | Drug Info |
T98390 Target Info |
Target Name | HUMAN angiotensin-converting enzyme 2 (ACE2) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Severe acute respiratory syndrome (SARS) | ||
Drugs | rhACE2 | Drug Info |
T00099 Target Info |
Target Name | HUMAN calpain-1/calpain small subunit 1 heterodimer (CAPN1/CAPNS1) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | BLD-2660 | Drug Info |
T86837 Target Info |
Target Name | HUMAN calpain-2/calpain small subunit 1 heterodimer (CAPN2/CAPNS1) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | BLD-2660 | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.